Jardiance (empagliflozin)

pCPA File Number: 22059
Negotiation Status:
Under consideration for negotiation
Indication(s):
adjunct to standard of care therapy for the treatment of chronic heart failure in adults
Sponsor/Manufacturer:
Boehringer Ingelheim (Canada) Ltd.
CADTH Project Number:
SR0726
pCPA Engagement Letter Issued:
Not Applicable
Negotiation Process Concluded:
Not Applicable